Agilent Technologies Inc vs NRG Energy Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while NRG Energy Inc trades at $120.38 (market cap $24.83B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and NRG Energy Inc pays the higher dividend (1.61%). Which is the better fit depends on your goals.
| A | NRG | |
|---|---|---|
Market Cap | $42.00B | $24.83B |
Sector | Health | Utilities |
52-Week High | $157.20 | $184.03 |
52-Week Low | $110.24 | $117.04 |
Enterprise Value | $43.55B | $48.79B |
Dividend Yield | 0.69% | 1.61% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
NRG Energy trades at $118.13, down 0.77% on the day, with a bearish technical signal and recent earnings misses in Q1 and Q2 2026. The company reported Q2 2026 adjusted EBITDA of $1.2 billion, up 34% year-over-year, and is advancing a 1.2-GW Texas data-center power project to drive growth. Valuation metrics show a P/E of 30.76 and P/S of 0.72, with a net income margin of 2.56% for 2025.
The outlook is mixed: strong analyst consensus (69% buy ratings) and a $207.83 price target suggest upside, but technical weakness, rising debt, and execution risks on new projects pose challenges. Revenue growth to $33.1B in 2026 and strategic investments in data center demand support long-term potential, though interest costs and leverage require monitoring.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →